Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Potenza Therapeutics IncfiledCriticalPotenza Therapeutics Inc
Publication of AR112904A1publicationCriticalpatent/AR112904A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
En el presente documento se proporcionan proteínas de unión a antígenos (ABP) que se unen selectivamente a GITR (proteína asociada al receptor del factor de mayor necrosis inducido por glucocorticoides) y sus isoformas y homólogos, y composiciones que comprenden las ABP. También se proporcionan métodos para utilizar las ABP, tales como métodos terapéuticos y de diagnóstico.Provided herein are antigen-binding proteins (ABPs) that selectively bind to GITR (glucocorticoid-induced major necrosis factor receptor associated protein) and their isoforms and homologues, and compositions comprising ABPs. Methods for using ABPs, such as therapeutic and diagnostic methods, are also provided.
ARP170103225A2016-11-192017-11-21
ANTI-GITR ANTIGENS BINDING PROTEINS AND METHODS FOR THE USE OF THEM
AR112904A1
(en)